Icon

TEGRETOL-XR (nda020234)- (100MG,200MG,400MG)

CARBAMAZEPINE NOVARTIS
100MG,200MG,400MG
Yes No
2011-Feb-08 Expired
None None
None No
Tegretol XR is indicated for use as an anticonvulsant drug (Epilepsy). Tegretol XR is indicated in the treatment of the pain associated with true trigeminal neuralgia.
13 0 11
Total Other Developers 18
Drugs with Suitability No
100MG ** ** Up - 7
200MG ** ** Up - 7
400MG ** ** Up - 7
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** **** ************** ********** ***. *** *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ****** ***** * * ********* *** *************** ******* *********** **** **. ***-***, *.*.*.* ********** ****, *******, ******, ***** (***) ***
****** ******* *** ******* ****** ************** **.,***. *********** **. ** ***** ****, **** ********, *******, ******** ******, ***** (***) ***
****** **** **** **** **** ************** **., ***. *********** **.** ****** ****, ******** *** ************* *********** ****, ************, ***** ******, ***** (***) ***
****** ******** ******* ****** **** ******** **., ***. *********** **, ******** **, **.** ******* ****, ********* ******* ****, ********* ****-**** ********** *********** *****, *********, ********* ******, ***** (***) ***
****** ******* ******* ************ ******* ******* *********** **** **. *** *** ***/*, ****, **** *****,, ****, ******* ******, ***** (***) ***
****** ******* ******** ******* *************** ***. *********** *** ***** *****, *********, ******** (**) *****, ****** ****** (***) ***
****** ****** **** ******* *************** **, *** *********** *** *** ***** ****, *********, *** ****** (**) *****, ****** ****** (***) ***
****** **** ****** *** ******* ******** ************** **., ***. *********** ******** ********** ****, ********* ****, ****** ********, ******* ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** **** **** ******-***** ************, *** *********** ***** **** *** *, ********, ********* (**) *****-****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.